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Abstract
Smith-Lemli-Opitz syndrome (SLOS) is an inborn error of metabolism affecting the last
step of cholesterol biosynthesis. It is characterized by a deficiency of the enzyme 7-
dehydrocholesterol reductase and accumulation of 7-dehydrocholesterol (7DHC) in cells
and body fluids. Given the similarities between 7DHC and cholesterol, 7DHC can be
incorporated into cell membranes in lieu of cholesterol. Nevertheless, due to their struc-
tural differences and distinct affinity to other membrane components, this substitution
alters membrane properties and one can expect to find abnormalities in membrane protein
composition. In order to identify differences in membrane proteins that could facilitate
our understanding of SLOS physiopathology, we isolated detergent-resistant membranes
(DRMs) from the skeletal muscle of Dhcr7T93M/T93M mice and C57/BL6 controls and
performed comparative proteomic analysis using iTRAQ for peptide quantification. A
total of 133 proteins were identified in the DRM fraction: 17 (13%) proteins demonstrated
increased expression in SLOS mice, whereas, 21 (16%) showed decreased expression.
Characterization of functional point of view and bioenergetics pathway and transmem-
brane transport responded to the major differences between the two groups of animals.
Keywords: skeletal muscle, detergent-resistant membranes (DRMs), Smith-Lemli-Opitz
syndrome, SLO, comparative proteomics, mouse model, Dhcr7T93M/T93M
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1. Introduction
Smith-Lemli-Opitz syndrome (SLOS), OMIM #270400, is one of the nine known disorders
associated with altered post-squalene cholesterol biosynthesis [1, 2]. This autosomal recessive
genetic disease was first described in 1964, as a syndrome of cognitive impairment and
multiple malformations [3]. Thirty years were needed to further characterize the disorder as a
metabolic disease and identify the underlying enzymatic defect. SLOS is caused by deficiency
of 7-dehydrocholesterol redutase (7-DHCR, 3-hydroxysteroid redutase, EC.1.3.1.21) which
catalyzes the conversion of 7-dehydrocholesterol (7DHC) to cholesterol, the terminal step of
Kandutsch-Russell pathway [4, 5]. Consequently, SLOS patients typically show increased
7DHC and decreased serum and tissue cholesterol levels [5]. In 1998, mutations of the 3β-
hydroxysterol Δ7-reductase gene (DHCR7) were shown to cause SLOS [6–8] and more than
154 DHCR7 mutations have been so far identified in SLOS patients [9]. The development of
animal models has improved the understanding of SLOS physiopathology and provided
material for in vivo and in vitro investigation of biological consequences of cholesterol defi-
ciency. In 2001, two mouse models with null mutations in Dhcr7 gene have been created by
homologous recombination [10, 11]. The malformations in the null mice are very mild com-
pared to what would be seen in a null human infant (i.e., SLO type II). The mutant mice died
within the first 24 h of extra-uterine life. Later, a mouse model with a milder phenotype was
developed [12]. This hypomorphic mouse has a missense mutation equivalent to the human
p.T93M, previously identified in SLOS patients often with Mediterranean heritage [13–15].
Like the majority of SLOS patients, the SLOS mouse models manifest a deficiency in choles-
terol biosynthesis resulting in low levels of cholesterol in serum and tissues [11].
Effective cholesterol biosynthesis is especially critical at certain stages during development
and continues to be important throughout life [16], since cholesterol is an essential lipid with
multiple functions. Cholesterol is a major lipid component of membrane microdomains, which
are crucial cell-surface dynamic structures responsible for many cellular signaling and com-
munication events [17]. Membrane domains can form through a number of mechanisms
involving lipid-lipid and protein-lipid interactions. One type of membrane domain is the
cholesterol-dependent membrane raft [18]. Properties of these membrane domains have been
primarily inferred from the study of detergent-resistant membranes (DRMs), composed by the
non-ionic-detergent insoluble, low-buoyant density membranous fractions of cells [19].
Although it was initially thought that such microdomains enriched in cholesterol exist exclu-
sively in the plasma membrane, increasing evidence suggests that similar lipid microdomains
(sometimes referred as raft-like microdomains) are also present in internal organelles [20–22]
with some of them being involved in the crosstalk between organelles [23].
Proteomics constitutes a powerful tool to study complex biological mechanisms and to identify
alterations in protein expression induced by changes in the environment, drugs, or disease
states. As such, proteomics is now widely employed to help understand pathological processes
induced by the disease [24–27]. The effect of an inborn error of cholesterol synthesis on skeletal
muscle has not previously been reported. In this chapter, we report a comparative analysis of
protein expression in skeletal muscle DRMs isolated from Dhcr7 T93M homozygous mutant
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mice (Dhcr7T93M/T93M) and wild type controls (Dhcr7+/+) controls. We analyzed sterols by GC–
MS and we used amine-reactive isobaric tagging reagents (iTRAQ) for quantitative sub-
cellular proteomics. We found the altered expression of key muscle proteins involved with
bioenergetics, membrane transport and Ca2+ homeostasis.
2. Material and methods
2.1. Materials
Butylhydroxytoluene (BHT), N,O-bis(trimethylsilyl) trifluoroacetamide (BSTFA), triethylammo-
nium bicarbonate (TEAB), trifluoroacetic acid (TFA), α-cyano-4-hydroxycinnamic acid (α-CHCA),
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), protease inhibitor cock-
tail, formic acid and urea were purchased from Sigma (Karlsruhe, Germany). RC DC Protein
Assay kit for protein quantification was from BioRad lab (Hercules, USA). The iTRAQ kit was
purchased from Applied Biosystems (Foster City, CA). Sequencing grade modified trypsin (bov-
ine) was from ABSciex (ABSciex, USA). HPLC-grade acetonitrile (ACN, Riedel, Seelze, Germany)
and Milli-Q grade water were also used. Rabbit raised polyclonal anti-caveolin 1 (ab2910) and
anti-annexin A2 antibodies were purchased from Abcom, Cambridge, UK. Analytical reagent
grade chemicals were used unless stated otherwise.
2.2. Animals
The T93M mutation [12] was backcrossed into C57/BL6 for three generations. Homozygous
(T93M/T93M) mice are viable and fertile [16]. Control C57/BL6 mice were obtained from IBMC
Animal Centre from Oporto University.
All the animals were housed in plastic cages with free access to water and food (cholesterol free
—chow -Mucedola, Ref: 4RF21). The animals were handled and maintained in controlled condi-
tions according to international standards. Animals were euthanized using deep isoflurane
anesthesia when they were 10 days old. Gastrocnemius and soleus muscles were dissected,
submerged in ice-cold buffer (TRIS, HCl, pH 7.4, 10 mM mercaptoethanol, 0.28 M sucrose) and
immediately frozen at 80C.
2.3. DRMs extraction
Detergent-resistant membranes (DRMs) were isolated using cold Triton X-100 treatment
followed by sucrose gradient centrifugation. In order to minimize individual variation, samples
were analyzed as pools of several animals. The procedure was adapted from Kim et al. [28].
Briefly, the samples were allowed to thaw slowly on ice, and tissue from three mice (approxi-
mately 300 mg) was minced with scissors, mixed with 700 µL of cold (4C) lysis buffer (25 nM
HEPES-HCl, pH 6,5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 and protease inhibitor
cocktail) and homogenized 30 times with a Poter homogenizer. The sample was maintained in
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an ice bath during homogenization and then incubated for 30 min at 4C. Aliquots of this
homogenate were collected for protein quantification and sterol analysis.
The resulting extract was mixed with an equal volume of cold sucrose 80% (w/v) to give a final
sucrose concentration of 40%, transferred to the bottom of a ultra-centrifuge tube (Ultra-clear
14  89 mm, Beckman Ref 344059) and overlaid carefully with 6.0 mL 30% and 3.0 mL 5% cold
sucrose solutions, containing 25 nM HEPES-HCl, pH 6.5, 150 mM NaCl, 1 mM EDTA, 1%
Triton X-100. Discontinuous sucrose gradients were centrifuged for 20 h, at 187,000 g on a
Sorvall Ultra Pro 80 UC, swinging bucket SW41 at 4C. The DRMs fraction, which collects at
the interface of the 5 and 30% sucrose layers, was isolated, washed with 9 mL of modified
HEPES buffer and centrifuged 30 min at 49,500 g at 4C. After centrifugation, the supernatant
was discarded and the pellet containing purified DRMs was suspended in phosphate buffered
saline (PBS) and stored frozen at 80C until further proteomic or sterol analysis.
2.4. Sterols analysis
For extraction of neutral sterols, 50 µL of sample was mixed with 50 µL of BHT 0.05% in
methanol (antioxidant), 50 µL of epicoprostanol 0.10 mmol/L (internal standard) and saponi-
fied at 60C for 1 h by 16 adding 1 mL of 4% (w/v) KOH in 90% ethanol. The samples were
then diluted with 1 mL of deionized water and the lipids were extracted twice with 2 mL of
hexane. The pooled hexane extracts were dried under a gentle nitrogen stream at room
temperature and derivatized with 50 µL BSTFA in 50 µL pyridine at 60C for 1 h [29]. The
trimethylsilylether derivatives of sterols were separated by GC–MS with a Supelco 28471_U
SLB-5MS column (30 m  0.32 mm i.d., 0.25 μm film thickness). The injector temperature was
set at 270C, and the splitless injection mode was used. The initial column temperature was
180C for 1 min and programmed to increase at a rate of 20C/min to 250C and then increased
again at 5C/min rate till 300C. The carrier gas was helium at a linear constant flow rate of
40 cm/s. The interface was programmed to 280C, the quadrupole to 150C and the ionization
source to 230C. After a solvent delay of 2.5 min, the eluted sterols were identified by their
retention times (comparing with commercial standards) and respective mass spectra and
quantified by selected ion monitoring (Table 1). The method was linear and reproducible for
the range of amounts assayed.
Sterol Retention time m/z
Epicoprostanol 13.02 370 257 355
Cholesterol 13.72 329 353 368
7DHC 14.02 325 351 366
Desmosterol 14.10 343 327
Sitosterol 14.80 357 396 486
Lathosterol 15.80 255 443 458
The m/z ions selected for sterol quantification are printed in bold.
Table 1. Sterol parameters.
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2.5. Proteomic profile
2.5.1. Pellet solubilization and protein quantification
Each assay involved four sample pools: a wt-BL6 control and a Dhcr7T93M/T93M and their
duplicates. For protein extraction, the DRMs pellets were treated with 10 volumes (w/v) of
solubilization buffer (7 M urea, 2 M thiourea, 1% (w/v) CHAPS, 1% (w/v) Triton X-100, 1% (v/v)
ampholytes (3–10) and 1 mM TCEP), sonicated briefly, then incubated for 10 min at room
temperature under agitation. Clear cell lysates were obtained by centrifugation at 12,000g for
30 min at 4C and saved for analysis. Insoluble material was discarded.
The protein concentration was determined by RC DC Protein Assay kit, using BSA to generate
the calibration curve.
2.5.2. Sample preparation for mass spectrometry analysis
Reduction, alkylation and digestion steps were performed according to the protocol provided
by the manufacturer. Briefly, 100 mg of DRM protein was mixed with TEAB buffer (1 M,
pH 8.5) and an enhancer of enzymatic digestion RapiGest (Waters) to give a final concentration
of 0.5 M and 0.1%, respectively. Samples were then treated with: (1) a reducing agent—TCEP
5 mM—used to break disulfide bonds within and between proteins, for 1 h at 37C and (2) a
cysteine (sulfhydryl group) blocking reagent—S-methylmethanethiosulfonate (MMTS) 10mM—
for 10 min, at room temperature. Then, 2 mg of trypsin was added to each sample and the
digestion was performed for 18 h at 37C. The digested tryptic specimens were dried using a
Speed-Vac. iTRAQ labeling was carried out according to the instructions provided by the manu-
facturer. Dhcr7T93M/T93M mice DRMs samples were marked with iTRAQ Tags 116 and wt-BL6
with114 and the duplicateswith 115 and 113, respectively. The labeled sampleswere combined in
pairs and dried in a Speed-Vac. The peptides were separated by reverse-phase liquid chromatog-
raphy as previously published [30].
2.5.3. LC-MS/MS analysis
Peptide mass spectra were obtained in the mass range 700–4500 Da on a MALDI-TOF/TOF mass
spectrometer (4800 Proteomics Analyzer, Applied Biosystems, Foster City, CA, USA) in the posi-
tive ion reflector mode. The obtained spectra were processed and analyzed by the ProteinPilot®
software (v4.0 AB Sciex, USA), which uses an algorithm for protein/peptide identification based on
the comparison of MS/MS data against the SwissProt protein database [31].
Protein clustering was performed according to biological and molecular functions derived
from the PANTHER classification system.
2.6. Immunocytochemistry assay
Immunocytochemistry assays were performed in order to confirm the presence of (1) caveolin-
1, a protein marker of a subtype of membrane microdomains which are rich in cholesterol,
designated caveolae (anti-caveolin-1 antibody dilution 1:500) and (2) annexin 2 another protein
associated with enriched cholesterol microdomains, that was found increased in the SLO
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mouse model (antibody dilution 1:2000). A sequential incubation with a secondary biotinylated
anti-rabbit antibody was performed and diaminobenzidine (which stains brown) was employed
as chromogen. Skeletal muscle samples were then counterstained with hematoxylin.
3. Results and discussion
3.1. Sterols
Sterols were extracted from two pools of biological samples: muscle homogenates and muscle
DRMs, and then analyzed by GC-MS. Results are presented as the average ratios between
sterols amounts. We observed a markedly elevated cholesterol/7DHC ratio in muscle homog-
enates from wild-type animals, reflecting the large amount of cholesterol and minimal levels of
its precursor (7DHC), in controls. This ratio was also much greater than one in Dhcr7T93M/T93M
mice, indicating that affected mice have significant residual 7-DHCR enzymatic activity and
are thus capable of producing significant amounts of cholesterol (Figure 1A).
Desmosterol is a cholesterol precursor by an alternative biosynthetic route, and there are no
significant differences in desmosterol levels between controls and affected animals. This is also
reflected in the 7DHC/desmosterol ratio. This parameter showed an enrichment ofDhcr7T93M/T93M
animals’ DRMs in 7DHC (Figure 1B). The ratio 7DHC/cholesterol also indicates that 7DHC is
preferentially incorporated in membrane microdomains (Figure 1C). These findings corroborate
the previous ones published by Rakheja and Boriack, based on liver analysis of SLOS patients,
which showed that 7DHC accumulates in hepatic DRMs [32]. Furthermore, while wt-BL6 controls
have essentially only cholesterol in DRMs, affected mice present a mixture of cholesterol and
7DHC (Figure 2).
Figure 1. Average ratios between the amounts of: cholesterol and 7DHC (A), 7DHC and desmosterol (B) and 7DHC and
cholesterol (C), extracted from skeletal muscle homogenates (M) and DRMs of wt-BL6 controls and hypomorphic
Dhcr7
T93M/T93M mice pooled samples.
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3.2. Proteomics
In order to explore the protein changes on sarcolemma, due to decreased 7-DHCR activity, we
analyzed DRMs utilizing iTRAQ labeling and LC-MS/MS.
A total of 133 unique proteins were identified. Those identified based on a single peptide and
those with a protein score less than 2.5 fold were excluded. Then a cut-off of 30% was applied to
iTRAQ average ratios allowing us to select proteins with an important variation in SLOS mice
relatively to controls. Differential protein expression was specific and not just a general finding.
Caveolin-1, a protein known to be expressed in cholesterol-rich membrane microdomains did
not show differential expression (Figure 3).
Of the 133 identified proteins, we observed an altered expression of 38 (29%) proteins. Increased
and decreased expression was observed for 17 and 21 proteins, respectively (Table 2). The
replicate samples demonstrated a strong positive correlation (r = 0.90) and indicated good
reproducibility (Figure 4).
Most proteins showing an altered expression in DRMs preparations were found to participate
in at least one of three main cellular processes: membrane trafficking, energy production and
Ca2+ homeostasis.
Figure 2. Comparative analysis of sterol composition of DRMs extracted from skeletal muscle of wt-BL6 controls and
hypomorphic DHCR7T93M/T93M (SLOS) mice.
Figure 3. Immunohistochemical stain for caveolin-1 (10) shows no significant differences betweenDhcr7 93M/93M (on the
left) and wt-BL6 (on the right) skeletal muscle samples.
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Total
score
Sequence
coverage %
Accession # Name Peptides
(95%)
SLOS/wt-
BL6
12.5 37 P07356 ANXA2_MOUSE Annexin A2 15 6.2
6.6 29 P16858 G3P_MOUSE Glyceraldehyde-3-phosphate
dehydrogenase
4 5.2
51.2 50 Q8R429 AT2A1_MOUSE Sarcoplasmic/endoplasmic reticulum
calcium ATPase 1
85 3.9
11.6 53 P07310 KCRM_MOUSE Creatine kinase M-type 12 2.7
6.7 41 P27573 MYP0_MOUSE Myelin protein P0 10 2.0
18.5 37 Q8K2B3 DHSA_MOUSE Succinate dehydrogenase [ubiquinone]
flavoprotein subunit, mitochondrial
18 1.9
17.4 59 P51881 ADT2_MOUSE ADP/ATP translocase 2 24 1.9
2.5 9 P09055 ITB1_MOUSE Integrin beta-1 3 1.9
29.5 56 P56480 ATPB_MOUSE ATP synthase subunit beta, mitochondrial 35 1.8
4.1 46 Q9D3D9 ATPD_MOUSE ATP synthase subunit delta, mitochondrial 4 1.6
14,5 14 O09165 CASQ1_MOUSE Calsequestrin-1 22 1.6
4,6 31 Q8C7E7 STBD1_MOUSE Starch-binding domain-containing protein 1 7 1.5
10.0 17 P70302 STIM1_MOUSE Stromal interaction molecule 1 7 1.5
25.4 70 P48962 ADT1_MOUSE ADP/ATP translocase 1 39 1.5
6.4 33 Q8VEM8 MPCP_MOUSE Phosphate carrier protein, mitochondrial 9 1.4
19.1 59 Q03265 ATPA_MOUSE ATP synthase subunit alpha, mitochondrial 27 1.3
3.0 47 Q9CQQ7 AT5F1_MOUSE ATP synthase subunit b1, mitochondrial 14 1.3
4.0 19 Q5U458 DJC11_MOUSE DnaJ homolog subfamily C member 11 3 0.8
23.3 45 Q8BMK4 CKAP4_MOUSE Cytoskeleton-associated protein 4 26 0.8
5.5 50 Q9CR68 UCRI_MOUSE Cytochrome b-c1 complex subunit Rieske,
mitochondrial
9 0.7
4.2 82 P99028 QCR6_MOUSE Cytochrome b-c1 complex subunit 6,
mitochondrial
13 0.7
5.0 73 P56391 CX6B1_MOUSE Cytochrome c oxidase subunit 6B1 9 0.6
5.1 2 Q8VDD5 MYH9_MOUSE Myosin-9 5 0.6
4.4 53 Q9DCS9 NDUBA_MOUSE NADH dehydrogenase [ubiquinone] 1 beta
subcomplex subunit 10
14 0.6
4.2 7 P99024 TBB5_MOUSE Tubulin beta-5 chain 7 0.6
20.1 46 P08121 CO3A1_MOUSE Collagen alpha-1(III) chain 25 0.6
26.0 56 Q9CZ13 QCR1_MOUSE Cytochrome b-c1 complex subunit 1,
mitochondrial
38 0.6
6.5 60 P97450 ATP5J_MOUSE ATP synthase-coupling factor 6,
mitochondrial
19 0.6
36.1 62 Q01149 CO1A2_MOUSE Collagen alpha-2(I) chain 47 0.6
5.3 15 Q9Z239 PLM_MOUSE Phospholemman 5 0.5
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Proteins with altered expression corresponded to a number of biological processes. We found
alterations affecting several membrane transporters. Even though no results from skeletal
muscle studies of SLOS are available, membrane trafficking abnormalities, in other cells har-
boring inborn errors of cholesterol biosynthesis, had already been reported. For example, in
cultivated human skin fibroblasts from SLOS patients the membrane fluidity is altered, cal-
cium permeability is augmented whereas folate uptake and membrane-bound Na+/K+ ATPase
activity are markedly decreased [33]. In agreement with these data, we now report decreased
expression of phospholemman, a small plasma transmembrane protein that acts as a channel
or channel regulator and modulates Na+/K+ ATPase activity [34, 35]. Further, we detected
significantly decreased expression of another integral membrane glycoprotein associated
with DRMs, the fatty acid translocase (FAT also called Cd36 or platelet glycoprotein 4) on
Total
score
Sequence
coverage %
Accession # Name Peptides
(95%)
SLOS/wt-
BL6
4.5 59 Q9CPQ1 COX6C_MOUSE Cytochrome c oxidase subunit 6C 6 0.5
66.9 35 P13542 MYH8_MOUSE Myosin-8 71 0.5
10.1 57 Q9D6J5 NDUB8_MOUSE NADH dehydrogenase [ubiquinone] 1 beta
subcomplex subunit 8, mitochondrial
13 0.5
3.0 29 Q99LY9 NDUS5_MOUSE NADH dehydrogenase [ubiquinone] iron-
sulfur protein 5
2 0.5
5.9 13 P68134 ACTS_MOUSE Actin, alpha skeletal muscle 5 0.4
8.8 46 P19783 COX41_MOUSE Cytochrome c oxidase subunit 4 isoform 1,
mitochondrial
12 0.4
2.6 3 P68369 TBA1A_MOUSE Tubulin alpha-1A chain 2 0.2
3.0 4 Q08857 CD36_MOUSE Platelet glycoprotein 4 2 0.2
Table 2. Proteins from the skeletal muscle DRMs with altered expression Dhcr7T93M/T93M mice.
Figure 4. Comparison of the individual ratio values found for 38 proteins of DRMs extracted from skeletal muscle, which
exhibited distinct levels of expression on hypomorphic Dhcr7T93M/T93M mice and wt-BL6 controls.
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sarcolemma of SLOS mice, responsible for the uptake of long chain fatty acids [36–39].
Upregulated transporters include mitochondrial phosphate carrier protein (which transports
inorganic phosphate into the mitochondrial matrix, essential for the aerobic synthesis of ATP)
and ADP/ATP translocases 1 and 2 (that catalyzes the exchange of cytoplasmic ADP with
mitochondrial ATP across the mitochondrial inner membrane).
These abnormalities of mitochondrial transporters may be indicative of more generalized
defect in mitochondrial function and ATP production. Decreased expression of subunits
corresponding to complexes I, III and IV of the oxidative phosphorylation (OXPHOS) system
was observed, while four ATP-synthase subunits showed increased expression (ATP synthase
mitochondrial subunits alpha, beta, delta and b1). Despite their mitochondrial origin, these
proteins should not be considered as contaminants of DRMs preparations. Several biochemis-
try and proteomic studies had already shown the presence of complex I and ATP-synthase
subunits in DRMs, [40, 41] and Poston showed that Triton X-114-resistant DRMs are also
present in mitochondria and contain proteins that facilitate ATP production and export from
this organelle [23], compatible with the increasing evidence of the presence of raft-like
microdomains in mitochondria [21, 42].
Ca2+ is one of the most important signaling compounds involved in various cellular processes
being intracellular Ca2+ levels tightly regulated by specialized proteins in the plasma mem-
brane, sarcoplasmic reticulum (SR) and mitochondria [43]. Recent studies suggest that mem-
brane rafts are involved in coordinating the protein interactions required for proper Ca2+
exchange between the MAM and mitochondria [23]. In the present study, we found increased
expression of four membrane proteins related with Ca2+ homeostasis namely: annexin A2,
sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1), calsequestrin-1 (CASQ1)
and stromal interaction molecule 1 (STIM1).
Annexin A2 is a calcium-regulated membrane-binding protein, which holds two calcium ions.
It has been proposed that it could play a key role in many processes including, (1) endocytosis
and (2) exocytosis, (3) ion channel conductance, (4) link of F-actin cytoskeleton to the plasma
membrane, (5) membrane organization, (6) formation of membrane cholesterol-rich micro-
domains and (7) regulation of cellular redox [44–46]. By LC-MS/MS, we found that annexin
A2 was six times more abundant in DRMs obtained from Dhcr7T93M/T93M mice than in wt-BL6
and then confirmed such difference by immunocytochemistry (Figure 5).
It is possible that the presence of 7DHC in SLOS mice membranes drives a higher annexin A2
incorporation in microdomains since 7DHC may promote microdomain formation [47]. An
alternate hypothesis would be that increased annexin A2 expression is related to its role in the
regulation of redox potential. In fact, several data suggest an increase of oxidative stress in
SLOS: (1) over a dozen of oxysterols have been produced from 7DHC by free radical oxidation
in solution [48], (2) the oxysterol mixture derived from 7DHC free radical oxidation is biolog-
ically active and leads to morphological changes in Neuro2a cells treated with these oxysterols
[49], (3) the synthesis of 3β,5α-dihydroxycholest-7-en-6-one (DHCEO), an oxysterol recently
identified as a biomarker of 7DHC oxidation (in fibroblasts from SLOS patients and brain
tissue), was found to be inhibited by an antioxidant compound in SLOS fibroblasts [47], (4)
retinas from a SLOS rat model contain high levels of lipid hydroperoxides [50], (5) 7DHC
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peroxidation is a major source of oxysterols observed in cells [51] and (6) we previously
identified a significant increase of the antioxidant enzyme superoxide dismutase mitochon-
drial in cultivated human SLOS fibroblasts. Considering these facts, we can hypothesize that
there is an alteration of redox state of the cells in SLOS and annexin 2 is overexpressed as a part
of cell strategy to compensate such a situation and protect cells’ biological compounds from
peroxidation.
Another Ca2+ binding protein found upregulated in SLOS was SERCA1 an intracellular pump
located in the SR of muscle cells, which catalyzes the hydrolysis of ATP coupled with the
translocation of Ca2+ from the cytosol to the SR lumen, thus contributing to calcium sequestra-
tion involved in muscular excitation/contraction process. Another protein from this group is
CASQ1, the major Ca2+-binding protein in the skeletal muscle SR. CASQ1 acts as an internal
calcium store in muscle. The release of calcium bound to this protein through a calcium release
channel triggers muscle contraction. Finally, stromal interaction molecule is a transmembrane
protein essential for the activation of store-operated Ca2+ entry (SOCE), a major Ca2+ influx
mechanism.
We also found integrin beta-1, overexpressed in affected mice. This microdomain-associated
protein belongs to the integrin family which incorporates heterodimeric transmembrane pro-
teins that function as major receptors for extracellular matrix proteins [52]. Integrin beta-1,
plays a role in the maintenance of the cytoarchitecture of mature muscle as well as in the
functional integrity of the muscle cells and is present at the neuromuscular junctions in skeletal
muscle ones [53]. One wonders if its overexpression could be one of the factors which protect
skeletal muscle from severe dysfunction in SLOS in opposition to other organs.
Ordered domains are formed when actin filaments attach to the plasma membrane [54]. Kwik
and collaborators found changes in the organization and activity of actin and actin-modifying
proteins after cholesterol depletion, and Gangully and Chattopadhyay demonstrated that
cholesterol depletion mimics the effect of cytoskeletal destabilization [55, 56]. Differences in
myofilaments and cytoskeleton proteins were also suspected in our study.
Furthermore, some of the proteins identified were not so far, according to the available bibliog-
raphy, associated with lipid-rafts or MAMs; nevertheless, they are involved in intracellular
Figure 5. Immunohistochemical stain for annexin A2 (4). Skeletal muscle samples of Dhcr793M/93M (left) and wt-BL6
(right). The Dhcr793M/93M (SLOS) sample shows a clear stronger coloration.
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physical connections like cytoskeleton-associated protein 4 (CKAP4) which is a transmembrane
protein that further to its function as receptor also links endoplasmic reticulum (ER) to the
cytoskeleton [57]. It is predictable that a membrane compact microdomain be involved in such
function, in order to provide further support to the anchor. Such hypothesis is sustained by the
fact that CKAP4 is a reversibly palmitoylated protein [58], and it is well described that
palmitoylation of cytoplasmic proteins regulates the interaction of these soluble proteins with
specific membranes or membrane domains. It is possible that palmitoylation controls the confor-
mation of transmembrane segments, to modify the affinity of a membrane protein for specific
membrane domains and to control protein–protein interactions [59].
Finally one should consider that both lipids and proteins for microdomains constructs are
synthesized in the ER/Golgi before transport to the plasma membrane and, indeed, those
proteins can be in a detergent-resistant, cholesterol-dependent state while residing there or in
vesicle trafficking [60].
4. Conclusion
Our purpose was to contribute to the biological characterization of this Dhcr7T93M/T93M
hypomorphic mouse model and identify differences that could help to go deeper in the
understanding of SLOS physiopathology.
Proteomic analysis of DRMs of skeletal muscular samples clearly show differences between
SLOS and wild-type mice, concerning proteins linked to membranes. The employed methodol-
ogy allowed us to identify further alterations related with calcium homeostasis and membrane
trafficking associated with SLOS and detected, for the first time, changes in mitochondrial
energy metabolism in this mouse model.
To the best of our knowledge, this is the first research study focusing on the skeletal muscle of
SLOS. The differential protein expression profile identified will open the way to comparative
studies with more severally affected disease mice models as well as to similar approaches in
human cells which may be helpful to uncover cellular mechanisms related to SLOS.
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FAT fatty acid translocase
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OXPHOS oxidative phosphorylation
PBS phosphate buffered saline
PIP2 phosphatidylinositol-4,5-biphosphate
SLOS Smith-Lemli-Opitz syndrome
Dhcr7
T93M/T93M Smith-Lemli-Opitz syndrome mouse, homozygous for T93M mutation
SR sarcoplasmic reticulum
STIM1 stromal interaction molecule 1
TEAB bicarbonate salt of triethylamine
TCEP tris(2-carboxyethyl)phosphine hydrochloride
TFA trifluoroacetic acid
UC ultra-centrifuge
VDAC voltage dependent anion-selective channels
wt-BL6 wild-type C57/BL6
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